We are live on
!
Find out more
TCM
TCG Crossover Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
1,165.83%
This Fund
S&P 500
This Quarter
Est. Return
-11.22%
1 Year Est. Return
+1,165.83%
3 Year Est. Return
+3,168.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$960M
AUM Growth
-$305M
(-24%)
Cap. Flow
-$75.3M
Cap. Flow
% of AUM
-7.85%
Top 10 Holdings %
Top 10 Hldgs %
64.7%
Holding
35
New
2
Increased
6
Reduced
4
Closed
3
Top Buys
| 1 |
ABVX
Abivax
ABVX
|
+$70.9M |
| 2 |
Disc Medicine
IRON
|
+$16.5M |
| 3 |
EyePoint Inc
EYPT
|
+$12.9M |
| 4 |
Savara
SVRA
|
+$10.5M |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$8.06M |
Top Sells
| 1 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$61.2M |
| 2 |
Geron
GERN
|
+$57.4M |
| 3 |
Structure Therapeutics
GPCR
|
+$37.1M |
| 4 |
ATXS
Astria Therapeutics
ATXS
|
+$24.6M |
| 5 |
KALV
KalVista Pharmaceuticals
KALV
|
+$13.8M |
Sector Composition
| 1 | Healthcare | 100% |
Similar funds
DILIC
IIM
KCM
ACM
BCP
AL
ACA
MSC